% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{Kubik:276068, author = {A. Kubik and I. P. A. das Virgens and A. Szabó and M. Váradi and A. Csizmarik and A. Keszthelyi and A. Majoros and P. Fehérvári and P. Hegyi and N. Ács and P. Nyirády and T. Szarvas$^*$}, title = {{C}omprehensive {A}nalysis of the {P}rognostic {V}alue of {C}irculating {MMP}-7 {L}evels in {U}rothelial {C}arcinoma: {A} {C}ombined {C}ohort {A}nalysis, {S}ystematic {R}eview, and {M}eta-{A}nalysis.}, journal = {International journal of molecular sciences}, volume = {24}, number = {9}, issn = {1422-0067}, address = {Basel}, publisher = {Molecular Diversity Preservation International}, reportid = {DKFZ-2023-00974}, pages = {7859}, year = {2023}, abstract = {Lymph node (LN) status is the most significant prognostic factor for invasive urothelial bladder cancer (UBC); however, the optimal extent of LN dissection (LND) is debated. We assessed circulating matrix metalloproteinase-7 (MMP-7) as a prognostic factor and decision-making marker for the extent of LND. Preoperative serum MMP-7 levels were determined in two independent UBC cohorts (n = 188; n = 68) and in one control cohort (n = 97) by using the ELISA method. A systematic review and meta-analysis on the prognostic role of circulating pretreatment MMP-7 levels were performed. Serum MMP-7 levels were higher in patients compared to controls (p < 0.001) with the highest levels in LN-positive cases. Half of LN-positive UBC patients had low MMP-7 levels, whereas the survival of LN-negative patients with high serum MMP-7 findings was poor. MMP-7 levels were independently associated with poor survival in both cohorts (p = 0.006, p < 0.001). Accordingly, our systematic review of six eligible publications revealed a 2.5-fold higher mortality risk in patients with high MMP-7 levels. In conclusion, preoperative MMP-7 level is a validated and independent prognostic factor in urothelial cancer. It cannot be used to decide between regional or extended LND but may be useful in identifying LN-negative high-risk patients with potentially undetected metastases.}, subtyp = {Review Article}, keywords = {Humans / Carcinoma, Transitional Cell / Urinary Bladder Neoplasms: pathology / Matrix Metalloproteinase 7 / Prognosis / Cystectomy: methods / Cohort Studies / Lymph Nodes: pathology / MMP-7 (Other) / biomarker (Other) / lymphadenectomy (Other) / matrilysin (Other) / micrometastases (Other) / overall survival (Other) / prognostication (Other) / radical cystectomy (Other) / urinary bladder cancer (Other) / urothelial cancer (Other) / Matrix Metalloproteinase 7 (NLM Chemicals)}, cin = {ED01}, ddc = {540}, cid = {I:(DE-He78)ED01-20160331}, pnm = {899 - ohne Topic (POF4-899)}, pid = {G:(DE-HGF)POF4-899}, typ = {PUB:(DE-HGF)16}, pubmed = {pmid:37175566}, pmc = {pmc:PMC10178327}, doi = {10.3390/ijms24097859}, url = {https://inrepo02.dkfz.de/record/276068}, }